Case Report Emergency Medicine
Association between pharmacist-led medication review and post-operative delirium: evidence from rural primary-care patients

Association between pharmacist-led medication review and post-operative delirium: evidence from rural primary-care patients

Authors

Yusuf Silva

Yusuf Silva

St Thomas' Hospital, Jersey

Lina Silva

Lina Silva

Singapore General Hospital, Qatar

Hana Lindqvist

Hana Lindqvist

St Thomas' Hospital, United Kingdom

Hugo Herrera

Hugo Herrera

Karolinska University Hospital, Heard Island and McDonald Islands

Sofia Kim

Sofia Kim

Mayo Clinic, Laos

Corresponding

Published

July 25, 2026

Paper ID

PAP-000281

Status

Published

DOI

10.65712/tmj.test000539

Association between pharmacist-led medication review and post-operative delirium: evidence from rural primary-care patients

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of post-operative delirium to health systems is substantial. Methods: We conducted a randomised controlled trial across 7 centres between 2017 and 2022. Results: post-operative delirium occurred in 7% of the intervention group versus 20% of controls. The adjusted odds ratio was 0.60 (95% CI 0.41 to 0.69). Conclusion: These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients.

Introduction

post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients. Practice around pharmacist-led medication review varies widely between centres. Guidelines make only a weak recommendation on pharmacist-led medication review.

post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients.

The cost of post-operative delirium to health systems is substantial. post-operative delirium remains a leading cause of avoidable harm among rural primary-care patients.

Discussion

Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded. Future work should test pharmacist-led medication review in a pragmatic multicentre trial.

Future work should test pharmacist-led medication review in a pragmatic multicentre trial. These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. These findings suggest that pharmacist-led medication review is associated with better post-operative delirium in rural primary-care patients.

Conclusions

Pharmacist-led medication review may be offered for rural primary-care patients to improve post-operative delirium.

References

1. Dubois S, Dubois L, et al. Prone positioning and patient satisfaction. BMJ. 2015;89(3):28-1189.

2. Rossi A, Kaur L, et al. Low-dose aspirin and post-operative delirium. Crit Care Med. 2025;348(7):882-1077.

3. Rahman M, Nasser A, et al. Low-dose aspirin and health-related quality of life. N Engl J Med. 2015;77(5):437-1192.

4. Mueller O, Schmidt O, et al. Vitamin D supplementation and glycaemic control. Pediatrics. 2016;73(4):329-978.

5. Lindqvist P, Silva X, et al. A sepsis alert system and time to diagnosis. Crit Care Med. 2015;363(2):70-1613.

6. Osei U, Mueller G, et al. Low-dose aspirin and surgical site infection. Crit Care Med. 2025;333(5):524-924.

7. Ahmed A, Osei K, et al. Vitamin D supplementation and medication adherence. Pediatrics. 2020;364(11):552-1155.

8. Osei D, Silva T, et al. Delayed cord clamping and in-hospital mortality. Diabetes Care. 2020;10(8):591-1123.

Appendices

Ethics approval: IRB-9864.

Materials and Methods

Missing data were handled with multiple imputation. We conducted a randomised controlled trial across 6 centres between 2019 and 2025. We conducted a randomised controlled trial across 5 centres between 2019 and 2023. We conducted a randomised controlled trial across 4 centres between 2019 and 2022.

Missing data were handled with multiple imputation. Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity.

Results

Effects were consistent across prespecified subgroups. 4023 participants were included (median age 68 years).

GroupnEventsRate %OR95% CI
Centre A88911338.70.720.40–1.33
Male7619220.80.870.51–1.34
Intervention625329.00.500.60–1.4
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of post-operative delirium
Shown for rural primary-care patients; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Distribution of post-operative delirium
Shown for rural primary-care patients; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. 2319 participants were included (median age 39 years).

Effects were consistent across prespecified subgroups. post-operative delirium occurred in 14% of the intervention group versus 14% of controls.